Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Cancers 2010, 2(2), 523-548; doi:10.3390/cancers2020523
Review

Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application

*  and
Received: 25 February 2010; in revised form: 1 April 2010 / Accepted: 7 April 2010 / Published: 14 April 2010
(This article belongs to the Special Issue Biomarkers: Oncology Studies)
View Full-Text   |   Download PDF [236 KB, uploaded 14 April 2010]
Abstract: Malignant mesothelioma (MM) is a rare and aggressive tumour of the serosal cavities linked to asbestos exposure. Improved detection methods for diagnosing this type of neoplastic disease are essential for an early and reliable diagnosis and treatment. Thus, focus has been placed on finding tumour markers for the non-invasive detection of MM. Recently, some blood biomarkers have been described as potential indicators of early and advanced MM cancers. The identification of tumour biomarkers alone or in combination could greatly facilitate the surveillance procedure for cohorts of subjects exposed to asbestos, a common phenomenon in several areas of western countries.
Keywords: biomarkers; malignant meosthelioma; asbestos exposure; early diagnosis biomarkers; malignant meosthelioma; asbestos exposure; early diagnosis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Tomasetti, M.; Santarelli, L. Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application. Cancers 2010, 2, 523-548.

AMA Style

Tomasetti M, Santarelli L. Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application. Cancers. 2010; 2(2):523-548.

Chicago/Turabian Style

Tomasetti, Marco; Santarelli, Lory. 2010. "Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application." Cancers 2, no. 2: 523-548.



Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert